Karolina Gaizauskiene

Mrs. Karolina Gaizauskiene

Radiology and Nuclear Medicine Center, Vilnius University Hospital Santariskiu Klinikos, Vilnius, Vilniaus Miestas, Lithuania
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2024 in Medicina
Verified
Journal Article
Open access
PDF file
KGKarolina Gaizauskiene
Karolina Gaizauskiene
KLKamile Leketaite
Kamile Leketaite
SGSigita Glaveckaitė
Sigita Glaveckaitė
NVNomeda Valevičienė
Nomeda Valevičienė
Background and Objectives: Over the past decade, there has been increasing attention paid to advanced and innovative cardiovascular magnetic resonance (CMR) modalities, such as T1 and T2 mapping, which play a major role in diagnosing diffuse myocardial disease. There is little data summarizing the current evidence regarding the diagnostic accuracy of T1 and T2 mapping, and extracellular volume (ECV) in acute myocarditis. The aim of our study was to select, analyze, and systematically review the recent scientific literature on the diagnostic value of CMR T1 and T2 parametric mapping in clinically suspected acute myocarditis. Materials and Methods: The literature search was performed in the PubMed database. Articles published in the years 2014–2024 were included in the analysis. At the initial stage, 458 articles were reviewed, and 13 exploratory research studies were further analyzed and presented in this systematic literature review. Results: The analysis included 686 patients with clinically suspected myocarditis and 372 subjects in the control group. The average age of patients with suspected myocarditis was 40.25 years; 26% of them were women. Prolonged native myocardial T1 relaxation time provides diagnostic accuracy in the setting of suspected acute myocarditis ranging from 69 to 99%, with sensitivity from 64 to 98% and specificity from 87 to 100%. Diagnostic accuracy of prolonged T2 relaxation time ranges from 47 to 87%, with sensitivity being from 48% to 94% and specificity from 60% to 92%. ECV alone showed moderate diagnostic performance, with diagnostic accuracy ranging from 62% to 76%, sensitivity from 47% to 73%, and specificity from 76% to 90%. T1 and T2 mapping and ECV, combined with the late gadolinium enhancement (LGE) technique, increases the probability of detecting myocardial inflammatory changes at various stages of the disease, improving the diagnostic accuracy to 96%. Conclusions: New quantitative CMR techniques, i.e., T1 and T2 mapping, have an advantage over conventional CMR sequences in detecting inflammatory myocardial structural changes and play an important role in diagnosing acute myocarditis. Incorporating these sequences in daily clinical practice increases the diagnostic value of CMR in acute myocarditis and becomes an alternative to endomyocardial biopsy, which has been considered the gold standard until now.

20 April 2014 in Sveikatos mokslai
Verified
Journal Article
Open access
PDF file
ŽPŽaneta Petrulionienė
Žaneta Petrulionienė
UGUrtė Gargalskaitė
Urtė Gargalskaitė
ASAgnė Skujaitė
Agnė Skujaitė
AUAgnė Urbonienė
Agnė Urbonienė
KGKarolina Gaizauskiene
Karolina Gaizauskiene
NVNomeda Valevičienė
Nomeda Valevičienė
Amiloidozė – tai grupė retų sisteminių ligų, kurioms būdingas sutrikęs baltyminių struktūrų susidarymas ir fibrilių formavimasis. Amiloidozės atsiradimą lemia didelis amiloido pirmtako kiekis organizme, nevisiškas amiloido pirmtako suirimas makrofagų sistemoje bei tam tikri audinių ypatumai. Nors liga sukelia sisteminius pakitimus, tačiau amiloido depozicijos laipsnis įvairiuose organuose skiriasi ir lemia skirtingas klinikines amiloidozės išraiškas. Širdies amiloidozė – tai klinikinis susikaupusio amiloido širdyje pasireiškimas. Širdies amiloidozės metu pagrindinis patogenezinis elementas – intersticinė amiloido infiltracija, sukelianti infiltracinę kardiomiopatiją, kuri progresuoja iki restrikcinės kardiomiopatijos ir širdies nepakankamumo. Širdies pažeidimas amiloidozės metu lemia itin blogą prognozę ir didelį mirštamumą. Todėl labai svarbu kuo ankstyvesnė diagnostika, kuri užkirstų kelią amiloido depozicijai įvairiuose organuose. Vis dėlto širdies amiloidozės diagnostika dažnai būna atlikta procesui esant toli pažengus, nes nėra specifinio klinikinio ligos pasireiškimo, todėl instrumentiniai tyrimai, patvirtinantys ligos diagnozę, atliekami per vėlai. Pagrindinis amiloidozės gydymas nukreiptas į infiltracinio proceso sustabdymą, kurio metu siekiama blokuoti amiloido depoziciją įvairiuose organuose ir į amiloidozės sukeltų komplikacijų gydymą, kuris mažina simptomus ir pagerina bendrą paciento būklę.

1 January 2023 in Seminars in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
KGKarolina Gaizauskiene
Karolina Gaizauskiene
GGGabrielė Glembockytė
Gabrielė Glembockytė
SGSigita Glaveckaitė
Sigita Glaveckaitė
NVNomeda Rima Valevičienė
Nomeda Rima Valevičienė
Summary: Non-compaction cardiomyopathy (NCC) is a rare pathology, but the exact rates of its prevalence are not known due to the lack of a diagnostic gold standard. The purpose of this article is to analyse the available cardiovascular magnetic resonance (CMR) diagnostic criteria of non-compaction described in the literature and to compare their sensitivity and specificity in the diagnosis of NCC. A search of available literature related to the CMR diagnostic criteria of myocardial non-compaction was conducted in the medical database PubMed in February of 2022. The period of publication of scientific articles covered the years from 1996 to 2022. A total of 7 full-text scientific articles were included in the final literature review. The main diagnostic criteria were used: the maximum non-compact (NCM) to compact myocardial layers (CM) ratio (NCM:CM), the percentage of trabeculated left ventricular (LV) myocardial mass, the percentage of trabeculated LV myocardial volume, the non-compact myocardial mass index of the total LV, and the determination of the total LV and the maximal fractal dimension (FD) of the apex with the use of fractal analysis. The lack of accurate diagnostic criteria results in an overdiagnosis of NCC. The highest sensitivity and specificity are associated with the maximum FD > 1.30 of the apex established by applying the fractal analysis method. Fractal analysis requires dedicated software, and this method is difficult to apply in routine clinical practice. Thus, the diagnostic criteria for the NCC using magnetic resonance imaging with higher diagnostic value remain to be sought.

10 September 2015 in Medicinos teorija ir praktika
Verified
Journal Article
Closed access
KGKarolina Gaizauskiene
Karolina Gaizauskiene
NVNomeda Valevičienė
Nomeda Valevičienė
DRDominyka Rimšaitė
Dominyka Rimšaitė
MPMarius Polianskis
Marius Polianskis
Sisteminė amiloidozė yra reta liga, kuri gali pažeisti inkstus, odą, kraujagysles, centrinę ir periferinę nervų sistemą, plaučius, kepenis, žarnyną ir širdį. Širdies miokardą pažeidžiantys tipai yra lengvųjų grandinių (AL) amiloidozė, kai kurios įgimtos arba paveldimos amiloidozės formos (ATTR, AApoA-I), senilinė sisteminė amiloidozė (SSA), izoliuota prieširdžių amiloidozė ir antrinė amiloidozė. 2008–2013 metais atliktas retrospektyvinis tyrimas VUL SK Radiologijos ir branduolinės medicinos centre. Darbo tikslas buvo patikslinti širdies amiloidozės diagnostines galimybes, pasitelkiant širdies magnetinio rezonanso tomografiją (šMRT), palyginti gautus duomenis tarp kontrolinės ir sergančiųjų širdies amiloidoze grupių. Tai pat patikslinti amiloidozei būdingą kontrastinės medžiagos (k/m) kaupimo pobūdį, miokardo pakitimus, stebimus šMRT. Keturiolikai pacientų, įtariant širdies amiloidozę, atliktas šMRT tyrimas, įvertinant pacientų amžių, diagnostinius miokardo pakitimo požymius, k/m kaupimo pobūdį. ŠMRT jautriausias neinvazinis tyrimo metodas širdies amiloidozei nustatyti. Širdies amiloidozės atveju šMRT tyrimo metu nustatome koncentrinę skilvelių hipertrofiją, normalaus dydžio skilvelius, prieširdžių padidėjimą, TPP hipertrofiją. Taip pat galime nustatyti kitus pakitimus, būdingus amiloidozei, tokius kaip skystį perikarde, skystį pleuros ertmėse, trombus širdies kamerose. Širdies amiloidozės atveju širdies funkcija išlieka normali, kol liga nepažengia toli. Širdies amiloidozės atveju KS miokarde charakteringas ryškus difuzinis subendokardinis ar transmuralus k/m kaupimas, neatitinkantis koronarinių arterijų perfuzijos baseinų. Apibendrinus mūsų tyrimo rezultatus, sergant širdies amiloidoze, KS_IF nesumažėja, bet reikšmingai sustorėja TSP ir KSUS. Stebimas specifinis simptomas – difuzinis vėlyvas k/m kaupimas T1 sekoje, papildomai diagnozuojamas skystis pleuros ir perikardo ertmėje.

31 July 2026 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
KGKarolina Gaizauskiene
Karolina Gaizauskiene
VSViktor Skorniakov
Viktor Skorniakov
DSDovile Silinskiene
Dovile Silinskiene
NVNomeda Valeviciene
Nomeda Valeviciene
SGSigita Glaveckaite
Sigita Glaveckaite
Background and aims: Limited data exist on the prognostic value of parametric mapping and late gadolinium enhancement (LGE) in patients with acute myocarditis (AM). This meta-analysis aimed to investigate the prognostic value of LGE as assessed by using cardiovascular magnetic resonance (CMR) in patients with AM, including more recent evidence. Additionally, the prognostic value of CMR parametric mapping was narratively reviewed. Materials and methods: The systematic search was conducted in the PubMed and Scopus databases from inception to January 17, 2026 (PubMed) and January 20th 2026 (Scopus). 1296 records were found through the search. Finally, sixteen studies were included in this systematic review. Thirteen studies were included in the meta-analysis on association between LGE and clinical outcomes in AM. The composite endpoint was defined as MACE and/or one of the following endpoints: all-cause death, heart failure decompensation requiring hospitalization, heart transplantation, and recurrent AM. MACE was defined as a composite of cardiovascular death (including sudden death), sustained ventricular tachycardia, ventricular fibrillation, complete atrioventricular heart block requiring a pacemaker, and cardiogenic shock. Five studies were reviewed for the prognostic value of parametric mapping parameters. After initial calculations, it appeared that studies using broader composite endpoints than only MACE introduced substantial heterogeneity. Therefore, we have additionally conducted analysis incorporating only eight studies with MACE as the endpoint. Results: The presence of LGE was associated with higher odds of the composite endpoint. The unadjusted pooled OR demonstrated a significant relationship between the presence of LGE and higher chances of the composite endpoint (OR LGE(+) vs. LGE(−) [95% CI] = 3.02 [1.40, 6.51], p < 0.001) with high heterogeneity (I 2 = 81.98%, p < 0.0001) On the qualitative level, results obtained in the MACE studies subgroup remained the same (OR LGE(+) vs. LGE(−) [95% CI] = 2.88 [2.01, 4.13], p < 0.0001). No clear evidence of publication bias was detected; however, power to detect small-study effects is limited and results should be interpreted cautiously. The prognostic value of parametric mapping parameters did not undergo meta-analysis and was reviewed narratively due to the shortage of the respective data. The data on the prognostic value of native T1, T2, and extracellular volume (ECV) are controversial and limited. Conclusions: Based on the findings, the presence of LGE appears to be associated with an adverse prognosis in patients with AM. However, these findings should be interpreted with caution because of substantial heterogeneity among studies and the unadjusted effect estimations. Evidence regarding the prognostic value of CMR-derived parametric mapping remains limited. Large, prospective, well-designed studies are needed to determine the incremental prognostic value of parametric mapping beyond LGE for risk stratification and outcome prediction in patients with AM.

17 June 2022 in Annals of Case Reports
Verified
Journal Article
Open access
PDF file
KGKarolina Gaizauskiene
Karolina Gaizauskiene
DPDarius Palionis
Darius Palionis
SGSigita Glaveckaitė
Sigita Glaveckaitė
NVNomeda Valevičienė
Nomeda Valevičienė
Background: To date, about 524 million cases have been diagnosed with COVID-19 infection worldwide. Cardiovascular complications of the COVID-19 infection such as acute coronary syndrome, heart failure, cardiogenic shock, arrhythmias, and myocarditis have been reported. Case Summary: A 29-year-old man presented with shortness of breath and swelling of the legs and genitals. Three months ago, the patient had a Covid-19 infection and pneumonia. Since then, shortness of breath has developed and progressed. ECG revealed sinus tachycardia and no ST-T elevation. Laboratory blood tests showed increased BNP, troponin I, D-dimer, and C-reactive protein levels. Transthoracic echocardiogram showed globally impaired left ventricular (LV) and right ventricular (RV) systolic function, enlargement of all heart chambers, fluid in the pericardial cavity, thrombus in the LV apex, and the right atrium (RA). Chest CTA revealed bilateral PE, LV, and RA thrombi, pericardial fluid, and bilateral lung infarcts. An intra-aortic balloon pump (IABP) was introduced. Later cardiac magnetic resonance imaging (MRI) was performed and revealed mid-myocardial and sub-epicardial late gadolinium enhancement (LGE) of the LV posterior and lateral walls and interventricular septum and signs of minimal focal edema in the midventricular segments. Patchy LGE was seen in the junction of both ventricles. Structural changes in the myocardium were characteristic of subacute-chronic myocarditis and dilated CMP. Discussion: Myocarditis after COVID-19 infection has been the most common cardiovascular complication. Cardiac MRI is the first-choice non-invasive diagnostic method to evaluate structural myocardial changes in acute or chronic myocarditis. Keywords: Myocarditis; COVID-19; Cardiac MRI; Cardiac imaging; Case report